wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33303627-4B906ECB-E9E5-4F94-B225-0EB48A7A35F7
Q33303627-4B906ECB-E9E5-4F94-B225-0EB48A7A35F7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33303627-4B906ECB-E9E5-4F94-B225-0EB48A7A35F7
Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B
P2860
Q33303627-4B906ECB-E9E5-4F94-B225-0EB48A7A35F7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33303627-4B906ECB-E9E5-4F94-B225-0EB48A7A35F7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
556cca03492f89ca03ce877058705c37f9a6e76b
P2860
Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma.